Leishmania donovani

Leishmaniasis life cycle diagram en

Leishmania donovani is a species of parasite that belongs to the genus Leishmania. It is the primary causative agent of visceral leishmaniasis (VL), also known as kala-azar, which is a severe form of leishmaniasis. This disease is endemic in parts of the tropics, subtropics, and the Mediterranean basin. L. donovani primarily affects the viscera or internal organs, particularly the spleen, liver, and bone marrow.

Life Cycle

Leishmania donovani has a complex life cycle that involves two hosts: a human (or other mammalian host) and a female sandfly of the genus Phlebotomus in the Old World or Lutzomyia in the New World. The life cycle alternates between the amastigote stage in the mammalian host and the promastigote stage in the sandfly.

In the mammalian host, the parasite exists as amastigotes, which are small, non-flagellated forms that reside within the macrophage cells of the host. When a susceptible sandfly bites an infected host, it ingests the amastigotes, which then transform into promastigotes in the sandfly's midgut. These promastigotes multiply and migrate to the sandfly's proboscis, ready to be transmitted to a new host during a subsequent blood meal.

Transmission

Transmission of L. donovani occurs through the bite of an infected female sandfly. The sandflies become infected by feeding on the blood of an infected mammal, where they ingest the amastigotes. The disease can also be transmitted through blood transfusions, organ transplants, and from mother to child (vertical transmission).

Symptoms and Diagnosis

Visceral leishmaniasis caused by L. donovani is characterized by fever, weight loss, enlargement of the spleen and liver, and anemia. If left untreated, the disease can be fatal. Diagnosis is typically made through the detection of the parasite in tissue samples, serological tests, or molecular methods such as PCR.

Treatment and Control

Treatment for visceral leishmaniasis includes the use of antimonial compounds, amphotericin B, miltefosine, and paromomycin. Control measures focus on reducing sandfly populations and minimizing human contact with sandflies. This can include the use of insecticide-treated nets, indoor residual spraying, and wearing protective clothing.

Epidemiology

Leishmania donovani is endemic in several regions around the world, including East Africa, the Indian subcontinent, and parts of the Mediterranean. The disease affects the poorest populations in these areas, with malnutrition, poor housing, and weak immune systems contributing to its spread.

Research

Ongoing research on Leishmania donovani focuses on understanding its biology, developing better diagnostic tools, and finding new treatments. Vaccine development is also an area of active research, although no effective vaccine is currently available for human use.